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Background: The purpose of this work was to investigate whether clinical cytology could be 
useful in the preoperative diagnosis of pelvic actinomycosis.
Methods: This study involved the prospective collection of samples derived from the 
endometrium and the uterine cervix, and retrospective data analysis. Nine patients with clinically 
diagnosed pelvic actinomycosis were enrolled. The clinical and hematological characteristics 
of patients were recorded, and detection of actinomyces was performed by cytology, pathology, 
and bacteriological culture of samples and by imprint intrauterine contraceptive device (IUD) 
cytology.
Results: The detection rate of actinomyces was 77.7% by combined cervical and endometrial 
cytology, 50.0% by pathology, and 11.1% by bacterial culture.
Conclusion: The higher detection rate of actinomyces by cytology than by pathology or 
bacteriology suggests that careful cytological examination may be clinically useful in the 
preoperative diagnosis of pelvic actinomycosis.
Keywords: actinomycosis, cytology, pathology, intrauterine contraceptive device, pelvic 
inflammatory disease
Introduction
Actinomycosis is a chronic suppurative, granulomatous inflammatory condition with 
abscess and fistula formation caused by anaerobic Gram-positive bacilli (Actinomyces 
species) commonly found within the oral cavity and intestinal tract of healthy 
individuals.1 It has been reported that pelvic actinomycosis is associated with chronic 
insertion of an intrauterine contraceptive device (IUD).2,3 A 20-year study in Japan 
of 122 women with pelvic actinomycosis revealed that 90.7% of them were IUD 
users.4 It is difficult to diagnose an actinomycotic adnexal mass by imaging modalities 
before surgery. Even with clinical features of actinomycosis, a pelvic mass containing 
a solid or cystic component is mostly diagnosed as suspected malignancy by either 
magnetic resonance imaging, computer tomography imaging, or ultrasonography.5 
Most cases of actinomyces are diagnosed by histopathological examination after 
surgery. Furthermore, actinomycotic adnexal abscesses progress slowly, with local 
invasion to adjacent organs. Thus, it is difficult to make a differential diagnosis of 
malignancy.6–8 Therefore, it is important to find some clinical modality to diagnose 
this slowly progressive disease preoperatively. Here we report nine cases of pelvic 
actinomycosis at our hospital along with an analysis of their clinicopathologic, 
cytologic, and bacteriologic characteristics. Our aim was to identify a single diagnostic 
intervention for pelvic actinomycosis before undertaking any operative procedure.
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During the period 2005–2010, nine patients diagnosed with 
pelvic actinomycosis were recruited for this study from 
the Department of Obstetrics and Gynecology, Nagasaki 
University. Papanicolaou smears and tissue samples 
were collected prospectively from the uterine cervix and 
endometrium, and data analysis was done retrospectively. 
Undertaking a transvaginal approach, cervical cytology 
by Hatta brushing (Soft Medical Co, Tokyo, Japan) and 
endometrial cytology using a spatula (Softcyte, Soft Medical 
Co, Tokyo, Japan) were performed by three operators (TT, 
KH, and MK). IUDs removed during the first visit or at 
surgery were used for imprint cytology by making a smear 
after direct touching on a slide glass. Papanicolaou staining 
was performed after alcohol fixation. Gomori’s methenamine 
silver stain was performed using the Papanicolaou-stained 
specimens. Endometrial tissue samples were collected by 
endometrial suction curette (Pipet Curet, MX140, Cooper 
Surgical, Trumbull, CT). We prospectively evaluated for 
the presence of actinomycosis in samples by cytological, 
pathological, and bacteriological examination. A bacterial 
culture system was used to cultivate vaginal discharge, 
IUD-adherent materials, and abscess contents derived from 
each patient using an Arginine glycerin salt agar plate. All 
prospective cytology, pathology, and bacteriology findings 
were retrospectively reanalyzed and the validity of the results 
was confirmed independently by experts in clinical cytology 
(KM) and in gynecological cytopathology and microbiology 
(HN and SM). We could remove only two IUDs before 
surgery in our study, and failed to remove the remaining 
seven IUDs.
Clinical features recorded from patient files included 
age, chief complaint, gravidity, parity, duration of IUD 
use, type of IUD inserted, patients with or without atypical 
genital bleeding and/or discharge, and operative procedure. 
Hematology (white cell count, red cell count, platelet count, 
C-reactive protein level) was analyzed and three tumor 
makers (CA125, CA19-9, CA54/61) were measured in the 
sera collected from these patients.
Results
Clinical findings and the operative methods used in our nine 
cases are described in Table 1. The mean patient age was 49.2 
(range 32–57) years. All women were parous and had an IUD 
inserted. The median duration of IUD use was 15.3 (range 
7–25) years. All women complained of lower abdominal 
pain and fever as the main clinical manifestation, and were 
diagnosed as having pelvic inflammatory disease during 
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their first hospital visit. All cases except one had had an 
IUD for more than 10 years. Information regarding the type 
of IUD inserted was unknown in three cases. Four women 
(44.4%) complained of atypical genital bleeding, with vaginal 
discharge of varying color noted in five cases (55.5%). Eight 
cases underwent hysterectomy and adnexectomy, and one 
case underwent segmental sigmoid colon resection.
The peripheral blood picture and serum tumor markers 
of our nine cases are shown in Table 2. All cases showed 
a remarkable increase in white cell count and C-reactive 
protein, indicating severe inflammatory changes. Seven 
of nine cases (77.8%) had increased serum platelet levels. 
Three serum tumor markers were measured to exclude 
malignancy, with some cases showing abnormal levels. 
Four of seven cases (57.1%) had abnormal serum tumor 
markers (Table 2).
The actinomyces detection rate as evaluated by cytol-
ogy, pathology, and bacteriology is shown in Table 3. Actino-
myces colonies were present in five of nine cases (55.6%) 
on cervical and/or endometrial cytology performed before 
surgery.
We detected actinomyces in four of nine patients (44.4%) 
by cervical cytology and three of eight cases (37.5%) by 
endometrial cytology (Table 3). Actinomyces were detected 
in a total of six patients (66.7%) by cytology of either the 
uterine cervix and/or endometrium or imprint IUD cytology 
before surgery. All three cases with imprint IUD cytology 
showed actinomyces colonies and bacterial threads which 
were confirmed by Gomori’s methenamine silver stain 
(Figure 1A–D). Imprint IUD cytology was done in three cases 
after IUD removal before surgery or from an IUD retained 
in the uterus after surgery. One patient (case 6 in Table 3) 
with positive imprint IUD cytology before surgery showed 
negative findings on both cervical and endometrial cytology. 
















1 382 1.2 43.4 38.0 6.5 39.1 ,0.6 ,0.2
2 383 2.2 77.2 38.6 15.9 22.1 ,0.6 3.3
3 410 1.4 30.5 39.0 14.2 17.9 ,0.6 ,0.2
4 436 1.8 34.4 38.3 24.1 – – –
5 420 4.4 71.4 37.6 22.9 25.1 18.8 –
6 452 1.9 51.7 37.8 17.4 28.1 2.8 ,0.2
7 258 1.7 40.4 39.1 19.6 15.1 9.7 2.6
8 410 2.3 55.4 38.0 22.0 – – 954
9 447 1.3 45.7 38.1 29.6 – – –
Abbreviations: rBC, red blood cells; WBC, white blood cells; BT, body temperature; CrP, C-reactive protein.
Actinomyces colonies were detected in two of four patients 
(50%) by Papanicolaou smear of abscess contents obtained 
during surgery. Case 5 in Table 1 showed a 2–3 mm sized 
yellowish-white granulated discharge present in the vagina 
and many actinomyces colonies on squash preparation 
(Figure 2A–C). Case 8 in Table 1 showed the presence of 
actinomyces colonies only in abscess contents of the right 
adnexa (Figure 3A and B).
We could identify actinomyces colonies in all cases 
either by cytology or histology with a clinical diagnosis of 
pelvic actinomycosis. However, bacteriological examination 
of vaginal discharge, IUD, and abscess content specimens 
obtained before surgery showed colony formation of 
actinomyces in only one patient (case 1 in Table 3), and 
was not detected after surgery. For four patients in whom 
pathological and bacteriological examination was unable to 
detect actinomyces, cervical or endometrial cytology was 
able to detect actinomyces in three cases.
Discussion
We demonstrate here that about 70% of pelvic actinomyces 
can be diagnosed by cervical and/or endometrial cytology 
or imprint IUD cytology before surgery, and the detection 
rate is even better when compared with pathological diag-
nosis after surgery. We found that three of four cases with a 
negative pathological diagnosis of pelvic actinomyces had 
actinomyces colonies on cervical or endometrial cytology. 
This result is clinically significant, even though we enrolled 
only a small number of patients in this study.
Information is limited in the literature regarding the 
preoperative diagnosis of pelvic actinomycosis using 
noninvasive procedures such as cervical or endometrial 
cytology. Abdominal actinomycosis develops most frequently 
in the gastrointestinal tract, especially around the ileocecal 
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junction, but pelvic actinomycosis in women is rare. 
Brenner and Gehring reported an increased incidence of 
pelvic actinomycosis in IUD users,2 and subsequent studies 
have found a close relationship between pelvic actinomycosis 
and prolonged IUD use.3,6–10 This is consistent with the 
findings of our study, in which all of our nine women had 
used an IUD for periods ranging from 7 to 20 years.
Keebler et al11 reported that the risk of actinomyces 
infection increased if an IUD is used for longer than 2 
years, with an infection rate of 8.4% (9/107) in women 
using an IUD for 1–2 years and 19% (16/84) for 2–3 years. 
Aoki and Imamura12 reported a similar infection rate in 
women who had used an IUD for a mean period of 3.5 years. 
Fujiwara and Koumoto4 reviewed 112 women with pelvic 
actinomycosis who had used an IUD for a period of two 
decades. In their study, the actinomycosis infection rate was 
90.7% for a mean period of IUD use of 9.8 (range 1.7–30) 
years. The average duration of IUD use in our cases was 
Table 3 Detection rate of actinomyces on cytology, pathology, and bacterial cultivation
Cases Cytological diagnosis Pathological 
diagnosis
Bacterial cultivation 
(Actinomyces spp.)Uterine  
cervix


















1 + + + + +: A.turicensis −
2 − + − −
3 − − − + − −
4 + − + − − −
5 + + − − −
6 − − + + − −
7 + + − − −
8 − − + − − −
9 − − − + − −
4/9 (44.4%) 3/8 (37.5%) 2/2 (100%) 1/1 (100%) 2/4 (50.0%) 4/8 (50.0%) 1/9 (11.1%) 0/9 (0%)




Figure 1 (A) Cytology of the endometrium, with basophilic granules of actinomyces seen with an inflammatory background (Papanicolaou stain, object lens magnification 
10×). (B) Magnified image of (A) (Papanicolaou stain, 40×). Thin filamentous mycelia are seen spreading outwards. (C) Imprint cytology of intrauterine contraceptive device. 
Many actinomyces colonies are seen within severe inflammatory background (Papanicolaou stain, 10×). (D) Gomori methenamine-silver stain of (C) showing presence of 
numerous blackish fine mycelia (40×).
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15.3 (range 7–25) years, which is longer than in any of the 
previous studies. The results of our study further strengthen 
the association between prolonged IUD use and actinomyces 
infection. Although the type of IUD was unknown in three 
of our cases, most of the cases positive for actinomyces 
infection used an FD-1 device. The link between occur-
rence of infection and this particular type of IUD needs to 
be investigated further.
Clinical features of pelvic inflammatory disease are 
abdominal pain, fever, and an increase in serum white blood 
cell and/or C-reactive protein levels. All of our cases attended 
hospital because of abdominal pain and fever, showed a 
marked increase in white blood cell and C-reactive protein 
levels, and had a clinical diagnosis of pelvic inflammatory 
disease (abscess in the pouch of Douglas or adnexa) before 
surgery. Cedermark et al13 reported that a raised platelet 
count might be useful to differentiate actinomycosis from 
other infections, and there have been similar reports from 
Japan.14,15 Seven cases (77.8%) in our study showed a marked 
increase in platelet count ($40 × 104/µL). An elevated platelet 
count with symptoms of pelvic inflammatory disease might 
be helpful in isolating cases with actinomycosis. From the 
bacteriological point of view, it is necessary to confirm a 
diagnosis of actinomycosis by bacterial culture; however, 
Figure 2 Brush cytology of granular discharge containing many actinomyces colonies (A) (Papanicolaou stain, object lens magnification 4×). (B) Magnified image of (A) 
(Papanicolaou stain, 40×) showing actinomyces strangles with abundant mycelia radiating outwards. (C) Gomori methenamine silver stain of (B) showing presence of blackish 
thin filamentous mycelia radiating outwards (40×).
Figure 3 Hematoxylin and eosin stain of sample derived from right adnexal abscess. (A) Basophilic actinomyces colonies are seen in the central hematoxylin-stained area 
and eosinophilic colonies are seen in the periphery (sulfur granules). Splendore-Hoeppli materials are also seen in the outermost layer (object lens magnification 20×). 
(B) Gomori methenamine silver stain of (A) showing abundant mycelia radiating outwards (20×).
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the detection rate by bacterial culture has been reported 
to be low. Hager et al16 reported a detection rate of 2% by 
bacterial culture and 8% by cytology. Similarly, Fujiwara 
and Koumoto4 reported that none of their 10 cases with 
actinomyces were able to be detected by bacterial culture. 
Therefore, actinomyces colonies are unlikely to be detected 
by bacteriological examination.
Actinomyces are fastidious bacteria that are difficult 
to isolate by culture. During bioculture of actinomyces, it 
is necessary to maintain strict anaerobic conditions in an 
environment containing 6%–10% carbon dioxide. In addition, 
detection by bacterial culture may be difficult on overnight 
incubation due to slow growth of actinomyces.17 This might 
explain why we could isolate actinomyces in only one sample 
by bacterial culture. The amount sampled, collection site, 
or timing of sample collection could also be important. In 
our study, samples from only one case showed actinomyces 
species (11.1%) by bacterial culture before surgery and not 
postoperatively.
Gupta et al18 reported the presence of actinomyces 
in the cervical smears of women using an IUD, which 
corresponded with subsequently published reports. The 
actinomyces detection rate by cytology was found to be 
as high as 8%–44% in IUD users, but as low as 0%–2.8% 
in nonusers.16,18,19 All of our patients used an IUD and our 
actinomyces detection rate by cervical cytology (44.4%) was 
similar to that in the published reports. We did not investigate 
the incidence of actinomyces in women who were not IUD 
users. Instead, we performed double cytology (cervical 
and endometrial) before surgery and found that combining 
these two cytological procedures with imprint IUD cytology 
before surgery may increase the detection rate to 66.7% when 
compared with cervical (44.4%) or endometrial (37.5%) 
cytology. Actinomycosis was detected in two of nine cases by 
imprint IUD cytology before surgery. One case had parallel 
positive findings by cervical cytology and another case had 
negative findings by cervical and endometrial cytology. This 
finding may be clinically important, favoring imprint IUD 
cytology before surgery in patients with clinically suspected 
actinomycosis presenting with positive findings for pelvic 
inflammatory disease and negative findings on cervical or 
endometrial cytology.
We suspected actinomycosis clinically because of the 
presence of granulated vaginal discharge and a history 
of prolonged IUD use, with subsequent confirmation on 
cytology and histology. The presence of sulfur granules is a 
definite marker for a pathological diagnosis. We could detect 
sulfur granules on postoperative histopathology in four of 
our eight patients (50%, Figure 3A). However, abundant 
sulfur granules are rarely visible on cytology without close 
examination of large numbers of samples.20,21
Diagnosis of pelvic actinomycosis is not possible by 
imaging. The image findings of actinomycotic adnexal 
abscesses are similar to that of malignancy, because 
actinomycotic adnexal abscess progresses with invagination 
deep into the peritoneum and fascia. Thus, it is difficult to 
differentiate malignancy from actinomycotic abscess by 
diagnostic imaging. Most cases of actinomyces are diagnosed 
postoperatively, with less chance (,20%) of a diagnosis before 
surgery.22 Although one of our cases was suspected to be 
malignant, all patients visited our hospital with the findings of 
a pelvic mass, a diagnosis of pelvic inflammatory disease, and 
with a history of prolonged IUD use before surgery. Our cases 
were compatible with a diagnosis of pelvic actinomycosis.
In conclusion, our higher detection rate of actinomyces 
by cytology than by pathology or bacteriology suggests that 
careful cytological examination may be clinically useful in 
the preoperative diagnosis of pelvic actinomycosis. Clinical 
features suggestive of pelvic actinomycosis and a prolonged 
history of IUD use require further investigation in a larger 
number of patients.
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